Pharmaceutical Technology

DECEMBER 4, 2022

Starting in January, multiple biosimilars of AbbVie’s blockbuster drug Humira are set to flood the US pharmaceutical market. While small molecule drugs can be remade into identical generics, biologics are more complex. For example, the first-to-market status was beneficial when it came to insulin biosimilars.

Marketing 262

Marketing Pharmacy Production Branding 262

Pharmacy Checkers

NOVEMBER 19, 2020

Prescription drugs are yet another thing you can get when you go to Amazon.com. Brand name drugs, ones without and even with generic competition, are similarly priced to other American pharmacies. How can they when the pharmaceutical industry has monopolistic pricing power over patented drugs? market to lower drug price.

Pharmacy 52

Pharmacy Insulin Branding Drugs 52

XTalks

SEPTEMBER 20, 2023

SmithRx, a pharmacy benefits management (PBM) company, joined forces with TheracosBio to facilitate patients’ access to the newly approved type 2 diabetes medication, Brenzavvy (bexagliflozin), through the Mark Cuban Cost Plus Drug Company platform. ” What is SmithRx? . ” What is SmithRx?

Pharmacy 64

Pharmacy Drugs Manufacturing Generic Drugs 64

The Pharma Data

DECEMBER 28, 2020

Food and Drug Administration (“FDA”) has approved its Abbreviated New Drug Application (“ANDA”) for Glucagon for Injection Emergency Kit, 1 mg. This further highlights Amphastar’s considerable abilities to bring complex generic drugs to the market, and more specifically, our strong peptide capabilities.”

Bioequivalency 52

Bioequivalency Production Sales Marketing 52

XTalks

FEBRUARY 8, 2021

In order to fact-check some of these misconceptions, the US Food and Drug Administration (FDA) recently hosted a webinar on biosimilar and interchangeable biological products to help healthcare professionals understand more about these treatment options. Biosimilars are the “generic” drugs of the biopharma world.

Production 78

Production Insulin Branding Generic Drugs 78

pharmaphorum

MARCH 3, 2022

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.

Insulin 52

Insulin Production Generic Drugs Medicine 52

pharmaphorum

MARCH 23, 2022

The US Senate will vote in the coming weeks on whether to introduce a $35 cap on the monthly cost of insulin to patients that was endorsed by President Joe Biden in his 2022 State of the Union address. Assuming the bill is later passed by the Senate and signed into law by President Biden, the insulin cap would take effect beginning in 2023.

Insulin 75

Insulin Production Generic Drugs FDA Approval 75

The Pharma Data

MAY 6, 2021

Taking double Covid-19 hits, Merck writes off $170M for scrapped drug, highlights $600M in missed sales ( Endpoints ). Biogen’s Alzheimer’s drug may only be cost effective at $2,500 a year ( STAT ). Biogen’s Alzheimer’s drug may only be cost effective at $2,500 a year ( STAT ). Reps.

Sales 52

Sales Vaccination Vaccine Gene Therapy 52

XTalks

AUGUST 2, 2023

Pfizer’s Top 5 Best-Selling Drugs of 2022: 1) Comirnaty Comirnaty is an mRNA-based vaccine indicated for the prevention of COVID-19. Comirnaty was first approved by the US Food and Drug Administration (FDA) in August 2021 for individuals over the age of 16. billion the drug generated in 2021. billion in 2022.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

XTalks

JANUARY 23, 2025

In its second interim staff report released January 14, 2025, the Federal Trade Commission (FTC) revealed that the top three pharma benefit managers (PBM) in the US inflated prices of specialty generic drugs over the past several years, resulting in them raking in billions of dollars in profits. What Is a PBM?

Drugs 59

Drugs Generic Drugs Pharmacy Insulin 59

Pharmacy Checkers

MARCH 11, 2020

Below is a copy of Gabriel Levitt’s comments on the FDA Notice of Proposed Rulemaking titled “Importation of Prescription Drugs” that were submitted Monday, March 9th, 2020. Comments on Notice of Proposed Rulemaking titled “Importation of Prescription Drugs, FDA-2019-N-5711, 84 Fed. 70796 “ Docket No.

Pharmacy 41

Pharmacy Drugs FDA Approval Licensing 41